STOCK TITAN
  1. Home
  2. Financials
  3. CRBP
  4. EPS (Diluted)

Corbus Pharmaceu (CRBP) EPS by Year

CRBP

Corbus Pharmaceu lost $5.90 per diluted share in fiscal year 2025. This represents a decrease of 60.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a loss of $6.11 per diluted share. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Corbus Pharmaceu has filed alongside them.

FY2025 annual
EPS (Diluted) -$5.90
YoY -60.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CRBP EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
EPS (Diluted)-$6.11-$5.90-60.3%-$3.68-$10.31-$10.15-$11.15N/AN/AN/AN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

CRBP EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)-$1.81-$1.23-$1.17-53.9%-$1.90-65.2%-$1.44-60.0%-$1.39-67.5%-$0.76+57.5%-$1.15-$0.90-$0.83-$1.79-$2.27

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Corbus Pharmaceu financials

Frequently Asked Questions

What was Corbus Pharmaceu's diluted earnings per share in fiscal year 2025?

Corbus Pharmaceu lost $5.90 per diluted share in fiscal year 2025.

How fast is Corbus Pharmaceu's diluted earnings per share growing?

Corbus Pharmaceu (CRBP) diluted earnings per share fell by 60.3% year over year, from -$3.68 to -$5.90 in fiscal year 2025.

What is Corbus Pharmaceu's diluted earnings per share over the last twelve months?

Corbus Pharmaceu (CRBP) reported a loss of $6.11 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Corbus Pharmaceu (CRBP) reported -$1.81 in diluted earnings per share in Q2 2026.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Corbus Pharmaceu (CRBP) reported on that line in every period on record.